Food News and Research

RSS

Compounding pharmacy trade group changes position on FDA oversight

The head of the nation's largest trade group for the specialty pharmacies known as compounders said he will support legislation requiring pharmacies that operate like drug manufacturers to register with the Food and Drug Administration and be subject to stricter standards enforced by the agency.

24 Feb 2013

WHO must play 'assertive central role' in fighting distribution of substandard, fake medicines

This Lancet editorial notes the release of an Institute of Medicine (IOM) report commissioned by the Food and Drug Administration (FDA) that gathers information on "the global threat of falsified or substandard drugs" and provides recommendations "to mitigate this public health problem."

23 Feb 2013

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.

23 Feb 2013

Viewpoints: Other GOP governors should note what Scott wrangled out of HHS; Curbs on painkillers need to be tougher

Those governors who earlier embraced ObamaCare's Medicaid expansion - here's looking at you, Jan Brewer - might be feeling a little cheated. If only they had held out a bit longer, they might have been able to obtain something from the Obama administration in return, as Florida's Rick Scott purports to have done.

23 Feb 2013

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA).

23 Feb 2013

Disruption in the body's circadian rhythm can increase risk of diabetes, heart disease

Disruption in the body's circadian rhythm can lead not only to obesity, but can also increase the risk of diabetes and heart disease.

22 Feb 2013

Unequivocal evidence that omega-3 fatty acids reduce breast cancer risk

A lifelong diet rich in omega-3 fatty acids can inhibit growth of breast cancer tumours by 30 per cent, according to new research from the University of Guelph.

22 Feb 2013

CB2 receptors might serve as potential therapeutic targets for cerebral ischemia

A new study published in the March issue of The American Journal of Pathology suggests that cortical type 2 cannabinoid (CB2) receptors might serve as potential therapeutic targets for cerebral ischemia.

22 Feb 2013

FDA approves new vial size for CSL Behring’s Privigen to treat primary immunodeficiency

CSL Behring today announced that the United States Food and Drug Administration has approved a 40 g (400 mL) vial size for Privigen, immune globulin intravenous [human].

21 Feb 2013

Weekend reading: Why a trip to the ER costs more than a college semester; Searching for the 'stomach share;' Lessons for the U.S. from Rwanda

Routine Care, Unforgettable Bills .... Sean was allowed to see the doctor only after he advanced MD Anderson $7,500 from his credit card. ... The total cost, in advance, for Sean to get his treatment plan and initial doses of chemotherapy was $83,900.

21 Feb 2013

Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences

Charles L. Sawyers, Chair of Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program (HOPP), was awarded the Breakthrough Prize in Life Sciences today. The award - established by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan, and Yuri Milner - recognizes "excellence in research aimed at curing intractable diseases and extending human life."

21 Feb 2013

Younger parents more likely to say online scores for physicians are very important

Numerous websites are available to rate just about any service or product: restaurant food, hotel service and even a pediatrician's care. However, a new poll from the University of Michigan shows that only 25 percent of parents say they consider doctor rating websites very important in their search for a child's physician.

21 Feb 2013

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “auriclosene” (pronounced awr-rih-CLO-zeen) for the Company’s lead Aganocide® compound NVC-422.

21 Feb 2013

Rising epidemic of obesity in the Asia Pacific region

Over eating, sedentary lifestyles, cultural attitudes, and lack of prevention programmes are to blame for the rising epidemic of obesity in the Asia Pacific region. Overweight and obesity has quadrupled in China and societies still label people of healthy weight as poor.

21 Feb 2013

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.

21 Feb 2013

Bracelet-like device with magnetic beads can control gastroesophageal reflux disease

A bracelet-like device with magnetic beads can control the chronic digestive disorder gastroesophageal reflux disease, according to a study published online today in the New England Journal of Medicine.

21 Feb 2013

Proposals, partisan rhetoric fly in countdown to March 1 spending cuts

News outlets report how spending reductions will impact health care programs. Meanwhile, in hopes of creating momentum toward a compromise, Alan Simpson and Erskine Bowles on Tuesday unveiled a $2.4 trillion proposal that includes $600 billion in spending reductions to health-care programs such as Medicare and Medicaid.

21 Feb 2013

BCHE gene variant predicts extent of plaque deposits in Alzheimer's

A study combining genetic data with brain imaging, designed to identify genes associated with the amyloid plaque deposits found in Alzheimer's disease patients, has not only identified the APOE gene -- long associated with development of Alzheimer's -- but has uncovered an association with a second gene, called BCHE.

21 Feb 2013

IRIN examines why humanitarian aid request remains constant in 2013 Sahel Regional Strategy

Noting "the 2013 Sahel Regional Strategy calls for $1.66 billion to help meet humanitarian needs and build up resilience among vulnerable groups -- an identical figure to the 2012 crisis appeal -- even though aid agencies estimate the number of Sahelians at risk of going hungry this year has dropped 44 percent to 10.3 million," IRIN examines "why the ask has remained constant."

21 Feb 2013

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children.

21 Feb 2013

Food News and Research

Compounding pharmacy trade group changes position on FDA oversight

WHO must play 'assertive central role' in fighting distribution of substandard, fake medicines

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

Viewpoints: Other GOP governors should note what Scott wrangled out of HHS; Curbs on painkillers need to be tougher

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Disruption in the body's circadian rhythm can increase risk of diabetes, heart disease

Unequivocal evidence that omega-3 fatty acids reduce breast cancer risk

CB2 receptors might serve as potential therapeutic targets for cerebral ischemia

FDA approves new vial size for CSL Behring’s Privigen to treat primary immunodeficiency

Weekend reading: Why a trip to the ER costs more than a college semester; Searching for the 'stomach share;' Lessons for the U.S. from Rwanda

Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences

Younger parents more likely to say online scores for physicians are very important

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

Rising epidemic of obesity in the Asia Pacific region

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

Bracelet-like device with magnetic beads can control gastroesophageal reflux disease

Proposals, partisan rhetoric fly in countdown to March 1 spending cuts

BCHE gene variant predicts extent of plaque deposits in Alzheimer's

IRIN examines why humanitarian aid request remains constant in 2013 Sahel Regional Strategy

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News